Dendritcellebaseret cancervaccine

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Dendritcellebaseret cancervaccine. / Burgdorf, Stefan K; Claësson, Mogens H; Rosenberg, Jacob.

I: Ugeskrift for læger, Bind 168, Nr. 14, 2006, s. 1420-3.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Burgdorf, SK, Claësson, MH & Rosenberg, J 2006, 'Dendritcellebaseret cancervaccine', Ugeskrift for læger, bind 168, nr. 14, s. 1420-3.

APA

Burgdorf, S. K., Claësson, M. H., & Rosenberg, J. (2006). Dendritcellebaseret cancervaccine. Ugeskrift for læger, 168(14), 1420-3.

Vancouver

Burgdorf SK, Claësson MH, Rosenberg J. Dendritcellebaseret cancervaccine. Ugeskrift for læger. 2006;168(14):1420-3.

Author

Burgdorf, Stefan K ; Claësson, Mogens H ; Rosenberg, Jacob. / Dendritcellebaseret cancervaccine. I: Ugeskrift for læger. 2006 ; Bind 168, Nr. 14. s. 1420-3.

Bibtex

@article{45697070f38911ddbf70000ea68e967b,
title = "Dendritcellebaseret cancervaccine",
abstract = "The varieties of treatments for patients with cancer have increased rapidly during the last few years. One of the newer ways to treat cancer patients is by immune therapy using tumor antigen pulsed dendritic cell-based vaccination. Phase I and II trials have shown effectiveness in generating an immunologic response and have in some cases shown clinical responses with tumour regression. This paper describes some of the possibilities and perspectives for dendritic cell vaccines for cancer patients. Udgivelsesdato: 2006-Apr-3",
author = "Burgdorf, {Stefan K} and Cla{\"e}sson, {Mogens H} and Jacob Rosenberg",
note = "Keywords: Antigens, Neoplasm; Cancer Vaccines; Dendritic Cells; Humans; Lymphocyte Activation; T-Lymphocytes",
year = "2006",
language = "Dansk",
volume = "168",
pages = "1420--3",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "14",

}

RIS

TY - JOUR

T1 - Dendritcellebaseret cancervaccine

AU - Burgdorf, Stefan K

AU - Claësson, Mogens H

AU - Rosenberg, Jacob

N1 - Keywords: Antigens, Neoplasm; Cancer Vaccines; Dendritic Cells; Humans; Lymphocyte Activation; T-Lymphocytes

PY - 2006

Y1 - 2006

N2 - The varieties of treatments for patients with cancer have increased rapidly during the last few years. One of the newer ways to treat cancer patients is by immune therapy using tumor antigen pulsed dendritic cell-based vaccination. Phase I and II trials have shown effectiveness in generating an immunologic response and have in some cases shown clinical responses with tumour regression. This paper describes some of the possibilities and perspectives for dendritic cell vaccines for cancer patients. Udgivelsesdato: 2006-Apr-3

AB - The varieties of treatments for patients with cancer have increased rapidly during the last few years. One of the newer ways to treat cancer patients is by immune therapy using tumor antigen pulsed dendritic cell-based vaccination. Phase I and II trials have shown effectiveness in generating an immunologic response and have in some cases shown clinical responses with tumour regression. This paper describes some of the possibilities and perspectives for dendritic cell vaccines for cancer patients. Udgivelsesdato: 2006-Apr-3

M3 - Tidsskriftartikel

C2 - 16584669

VL - 168

SP - 1420

EP - 1423

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 14

ER -

ID: 10155623